• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,702.98 -735.30
(-1.55%)
Dow Jones
6,694.68 -102.12
(-1.50%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,300.41 -53.36
(-0.52%)
Forex
USD-INR
91.92 0.02
(0.02%)
EUR-INR
106.58 -0.28
(-0.27%)
GBP-INR
123.39 -0.12
(-0.10%)
JPY-INR
0.58 0.00
(-0.46%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
37.7
744.57
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.24
 

kd green industries ltd
Arfin India rises after securing Rs 321-cr repeat order from Diamond Power Infra
Dec 29,2025
The order entails the supply of 11,000 metric tonnes over an eleven-month period from January to November 2026, implying an average monthly dispatch of around 1,000 MT. The company estimates the monthly order value at approximately Rs 29.2 crore.

This is a repeat order from the same customer. Arfin India had earlier secured an order for 1,000 MT valued at about Rs 29.2 crore and said the latest contract strengthens its long-term customer relationship and market presence.

Arfin India manufactures and trades in non-ferrous metals.

The company reported a 5% drop in consolidated net profit to Rs 2.45 crore on a 14.2% decline in revenue from operations to Rs 127.94 crore in Q2 FY26 over Q2 FY25.